Three questions answered by Bengbu health and Family Planning Commission

Source: is it appropriate for Zhongan online to record bad behaviors in relevant pharmaceutical companies on April 28, 2015? Before the reporting of adverse records has not been implemented yet, the purchasing consortium said in an open letter to pharmaceutical enterprises that the pharmaceutical enterprises failing to meet the reduction will be reported to the provincial pharmaceutical purchasing platform by the consortium, and the application will be recorded in the adverse behavior record once At the same time, report to the provincial medical reform office and the national medical reform office, and apply for the record of bad behaviors of enterprises In response, the head of the medical administration department of the health and Family Planning Commission said that at present, 8 pharmaceutical enterprises have been banned, and the consortium and the health sector are carrying out a number of work Que Shengli, chief of the medical administration department, said that at present, the company's bad behavior has not been reported After the purchase behavior is over, "make an overall evaluation on the pharmaceutical companies, see how many companies still have the behavior of no price reduction, and then decide whether to report or not." A number of pharmaceutical companies involved chose to "lose their voice" yesterday, the reporter contacted some of the banned pharmaceutical companies, but curiously, none of them responded The reporter first contacted Han manager of Guangzhou Baiyunshan Pharmaceutical General Factory in Anhui Province, but Han said he did not know the news that the drug was banned in Bengbu In Tianjin HongRi Pharmaceutical Co., Ltd., the other side said that the relevant person in charge was not available on the same day and could not reply In Harbin Songhe Pharmaceutical Co., Ltd., the reporter provided the contact information The other side said that someone would reply to the reporter, but as of the time of publishing, there was no contact with the reporter In Jiangsu aosaikang Pharmaceutical Co., Ltd., the other side directly said that it was not convenient to disclose this matter In fact, why eight pharmaceutical companies refuse to "cut meat" is mainly based on two aspects, according to the analysis of some local insiders First of all, some well-known domestic pharmaceutical companies have some exclusive drugs in their hands, so as to fight against the price reduction requirements At the same time, considering the large market share in the whole country, if we start in Bengbu, it is likely to affect the drug prices in other regions On balance, it's better to abandon individual markets to maintain drug prices in other regions It is also understood that, after being informed of the killing, some enterprises involved are in urgent consultation with Bengbu Federation and health and Family Planning Commission [progress] Bengbu pharmaceutical supplement is in the process of interest game between pharmaceutical enterprises and consortia, but for the local people, it is more closely related to the problem of drug disconnection after the closure of related pharmaceutical enterprises In fact, on April 19, Bengbu health and Family Planning Commission issued a notice to 94 public medical institutions in the city In order to ensure the later clinical use, all medical institutions are required to prepare for the supplement of drug varieties According to the notice, the reporting work of each hospital was completed on 23 this month In an interview yesterday afternoon, the head of the medical administration department of Bengbu health and Family Planning Commission admitted that some of the eight drug companies that had been banned before were under exclusive control "After preliminary investigation and supplement, there are not many exclusive drugs involved, and we are also actively looking for alternatives." In the future, Anhui will be the pilot province of deepening medical reform After the 94 public medical institutions in Bengbu City became a "drug volume procurement Consortium", they took the lead in the province to challenge drug companies "We hope to take a good lead," said the head of Bengbu health and Family Planning Commission in the interview For the centralized purchase of single drug, they asked enterprises to reduce the price by 25% on the basis of provincial bidding price "After our early research, it's totally bearable for pharmaceutical enterprises," said que Shengli, chief of the medical administration department At present, most pharmaceutical enterprises in this procurement have "reached the standard", which also proves this point Que Shengli said that only when the consortium insists on negotiating prices with pharmaceutical enterprises for a long time in the bidding process of centralized drug procurement, can it really reach the bottom of drug prices The general office of the State Council has previously issued the guiding opinions on improving the centralized drug purchase in public hospitals, which has made it clear that "in the pilot city of public hospital reform, it is allowed to purchase drugs on the provincial centralized drug purchase platform by the city as a unit" The second price negotiation was affirmed by the national policy In this regard, some insiders said that the practice of "cutting down the price of winning the bid in medicine province" similar to that of Bengbu City would be imitated by various pilot cities of medical reform "The second negotiation is not only in Bengbu, but also in Shaoxing, Ningbo, Baoji and other cities in other provinces." Liu Xuejie, director of Bengbu health and Family Planning Commission, said it can be predicted that "second bargaining" will become the new normal in the industry "Eight pharmaceutical enterprises including Baiyunshan in Guangzhou were blocked by nearly 100 hospitals in Bengbu" tracking many involved pharmaceutical enterprises to choose "lost their voice" a few days ago, this newspaper reported the event that nearly 100 public hospitals in Bengbu jointly blocked eight famous pharmaceutical enterprises Yesterday, Bengbu health and Family Planning Commission responded to relevant issues According to reports, 25% of the price reduction is from the results of joint demonstration by experts, which is completely within the range of pharmaceutical enterprises Yesterday, a Japanese newspaper reporter contacted several pharmaceutical companies involved, but no response was received At the same time, the reporter learned that Bengbu has become the first "second bargaining" area in drug procurement in our province, and this measure will become a new normal in the future How does the 25% reduction come from? It is through the collective demonstration of experts that we can cut down 1 / 4 of the price in one stroke, and many pharmaceutical companies are crying out for pain At the same time, there are also voices questioning the "25% drop in data" and what's the point? Que Shengli, chief of medical and Political Department of health and Family Planning Commission of Bengbu City, believes that it is an indisputable fact that the price of drugs has been falsely high, and that the 25% reduction is entirely within the scope of the enterprise "The 25% price reduction of the top 30 drugs is not casually stated, but the figure obtained through the collective demonstration of experts." According to reports, these experts are all from the whole medical system pharmaceutical industry in Bengbu City, and they have a good understanding of the bottom price of drugs Why should we ban drug companies that fail to reduce prices? Too many "small actions" of pharmaceutical enterprises lead to the closure of the consortium as the buyer and the pharmaceutical enterprise as the seller, which is a market behavior Why do eight enterprises finally encounter the punishment of being out of the game? In que Shengli's view, although it is market behavior, medicine is different from green vegetable radish, "it not only has the interest game in market behavior, but also has social responsibility." He believes that there is room for drug companies to reduce prices, but they are always reluctant to do so, which is a bad behavior in itself At the same time, que Shengli also revealed a detail that some pharmaceutical companies had joined forces to fight against the demand of purchasing consortia for price reduction "The medical administration department and the procurement consortium have communicated with some pharmaceutical companies for many times, hoping that the other side can reduce the price, but some pharmaceutical companies not only disagree, but also hope to unite with other pharmaceutical companies to fight against the requirements of the government departments and the procurement consortium through a group approach." It is understood that in the centralized procurement bidding held on 21st of this month, 8 enterprises still haven't given the reply whether the consortium promises to reduce the price until 6 p.m Therefore, the purchasing consortium made the decision to block 8 pharmaceutical companies.